(R) - (+) -HA-966 (Standard)

[1]Hutson PH, et al. R- (+) -HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br J Pharmacol. 1991 Aug;103 (4) :2037-44.|[2]Witkin JM, et al. Discriminative stimulus effects of R- (+) -3-amino-1-hydroxypyrrolid-2-one, [ (+) -HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther. 1995 Dec;275 (3) :1267-73.|[3]Christensen D, et al. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+) -HA966 in a rat model of peripheral neuropathy. Br J Pharmacol. 1998 Dec;125 (8) :1641-50.